Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid Arthritis

Ling, S.F. orcid.org/0000-0001-8148-2344, Ogungbenro, K., Darwich, A.S. orcid.org/0000-0001-8218-4306 et al. (9 more authors) (2024) Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid Arthritis. Pharmaceutics, 16 (6). 702. ISSN 1999-4923

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2024 by the authors. This is an open access article under the terms of the Creative Commons Attribution License (CC-BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.

Keywords: rheumatoid arthritis; pharmacokinetics; population pharmacokinetics; simulation; biologics; biosimilars
Dates:
  • Published: June 2024
  • Published (online): 23 May 2024
  • Accepted: 20 May 2024
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM) > Discovery & Translational Science Dept (Leeds)
Funding Information:
Funder
Grant number
NIHR National Inst Health Research
BRC
MRC (Medical Research Council)
R116825
NIHR National Inst Health Research
NIHR202395
Depositing User: Symplectic Publications
Date Deposited: 13 Jun 2024 08:43
Last Modified: 13 Jun 2024 08:43
Status: Published
Publisher: MDPI
Identification Number: 10.3390/pharmaceutics16060702
Open Archives Initiative ID (OAI ID):

Export

Statistics